stocksEPIGRAL
1,249.20+8.3 (+0.67%)
26 Aug, 3:30 PM

Annual Reports and Financial Documents

Epigral Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Epigral Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Analyst / Investor Meet18 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday, 20.08.2026
  2. Analyst / Investor Meet7 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Epigral Limited hereby informs that the officials of the Company are participating in EMKAY Confluence 2026 on 12th August, 2026
  3. Analyst / Investor Meet30 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Epigral Limited informs that the Company is having One-on-One Meeting with Investor / Analyst on Monday, 3rd august, 2026.
  4. Newspaper Publication29 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newpaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026
  5. Newspaper Publication29 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026
  6. Analyst / Investor Meet27 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording of Conference Call discussing Q1 FY27 Results held on Monday, 27th July, 2026 at 5.00 p.m.
  7. Press Release / Media Release27 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release of Un-Audited Financual results - Q1FY27.
  8. General27 Jul 2026
    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') - Outcome Of Board Meeting
    As part of the Company''s strategic growth and expansion initiatives, it proposes to establish a new manufacturing facility for Epoxy Resin and formulations and Multi Purpose Plant at its ....
  9. Outcome of Board Meeting27 Jul 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, 27Th July, 2026 And Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The First Quarter Ended 30Th June, 2026.
    Outcome of Board Meeting held on Monday, 27th July, 2026 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the First Quarter ended 30th June, 2026.
  10. General22 Jul 2026
    Epigral Limited''s Reply To Clarification Sought With Reference To Movement In Volume.
    Epigral Limited''s reply to clarification sought by the Stock Exchange with reference to Movement in Volume.
  11. Analyst / Investor Meet22 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Epigral Limited has informed the Exchange about Conference Call on Monday, 27th July, 2026 to discuss Q1 FY27 Results
  12. Board Meeting22 Jul 2026
    Board Meeting Intimation for Intimation Of The Board Meeting Of Epigral Limited Scheduled To Be Held On Monday, 27Th July, 2026.
    Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 ,inter alia, to consider and approve Un-audited Financial Results (Standalone ....
  13. Credit Rating14 Jul 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Revised Credit Rating.
  14. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Epigral Limited submits certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2026
  15. Acquisition7 Jul 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Epigral Limited has informed the Exchange about Incorporation of a Wholly owned Subsidiary namrly "Epigral Advanced Materials Limited".
  16. Closure of Trading Window27 Jun 2026
    Closure of Trading Window
    Epigral Limited submits Notice of Closure of Trading Window
  17. Analyst / Investor Meet10 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on June 16, 2026.
  18. AGM9 Jun 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Submission of Scrutinizer''s Report of 19th AGM held on 08.06.2026.
  19. AGM8 Jun 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceedings of 19th AGM held on 08.06.2026.
  20. Credit Rating3 Jun 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Epigral Limited submit Review of CRISIL Ratings on the Bank Facilities of Epigral Limited.

Frequently Asked Questions

Where can I download the annual report of Epigral Ltd.?
Annual reports of Epigral Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Epigral Ltd.?
Quarterly earnings results and presentations of Epigral Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Epigral Ltd. publish earnings call transcripts?
Earnings call transcripts of Epigral Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Epigral Ltd.?
Investor presentations and annual day presentations of Epigral Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Epigral Ltd.?
Corporate announcements and regulatory filings of Epigral Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Epigral Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Epigral Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Epigral Ltd.?
The ISIN (International Securities Identification Number) of Epigral Ltd. is INE071N01016. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Epigral Ltd. listed?
Epigral Ltd. is listed on NSE and BSE. The NSE symbol is EPIGRAL and the BSE code is -.
Where can I find the shareholding pattern of Epigral Ltd.?
The quarterly shareholding pattern of Epigral Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Epigral Ltd. on Sharpely?
Share price data for Epigral Ltd. is updated as of 26 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.